Latest Health News
Gene‑edited immune cell therapy produces deep remissions in aggressive T‑cell leukaemia in early UK trial
Early clinical trial of a base‑edited donor immune cell therapy for aggressive T‑cell leukaemia reported most patients achieved deep remission and remained disease‑free up to three years, offering hope for a previously treatment‑resistant cancer; researchers caution larger trials are needed to confirm long‑term safety and broader applicability.
WHO: attacks on health care in Sudan becoming deadlier and more widespread
The World Health Organization reports a dangerous escalation of attacks on health care across Sudan that is cutting off access to lifesaving services, endangering health workers and humanitarian operations, and documenting hundreds of verified incidents since the conflict began.
Measles surges in multiple countries, including Brazil and the USA
ProMED and regional reports show accelerating measles cases in Brazil (São Paulo) and multiple US states, reflecting ongoing outbreaks tied to gaps in vaccination coverage and prompting heightened surveillance and response measures.
Dengue outbreaks intensify in Bangladesh and other tropical regions
ProMED alerts indicate rising dengue activity in Bangladesh and other endemic areas, with health authorities reporting increased case counts and expanded vector‑control efforts to reduce transmission and hospital burden.
WHO and ReAct Africa partner to strengthen efforts against antimicrobial resistance (AMR)
The WHO Regional Office for the Eastern Mediterranean signed an MoU with ReAct Africa to enhance collaboration on antimicrobial resistance, aiming to bolster surveillance, stewardship and access to effective treatments across the region.
Northwestern experimental drug halts Alzheimer‑like disease in animal model before symptoms
Northwestern University researchers reported an experimental compound (NU‑9) that prevented Alzheimer‑like pathology in an animal model when given prior to symptom onset, suggesting potential for early‑intervention strategies pending further research.
Rapid 15‑minute hepatitis C test could transform diagnostics
Northwestern‑linked research (reported via ScienceDaily) describes a rapid PCR‑based hepatitis C test delivering accurate results in 15 minutes, which could greatly expand point‑of‑care diagnosis and linkage to treatment if validated and scaled.
New gut microbiome molecules linked to obesity and diabetes regulation
Harvard‑linked research found specific gut‑bacteria‑derived molecules that travel to the liver and modulate energy use and insulin response, pointing to possible microbiome‑based therapies for obesity and metabolic disease.
Natural compound forskolin enhances chemotherapy responses in aggressive leukemia models
Preclinical studies show forskolin, a plant‑derived compound, not only inhibits growth of aggressive leukemia cells but also increases their sensitivity to chemotherapy, suggesting a potential adjunctive strategy requiring clinical evaluation.
Rising concern over Kyasanur Forest disease and other zoonotic threats in India and region
ProMED flagged updates on Kyasanur Forest disease in Karnataka, India, alongside multiple zoonotic alerts (hantavirus, brucellosis, tularemia) in the Americas and Africa, underscoring persistent spillover risks and need for surveillance.
Advances in myasthenia gravis therapies: rozanolixizumab and nipocalimab reshape treatment options
2025 saw regulatory and clinical progress for FcRn‑targeting therapies in myasthenia gravis, including EU approval for self‑administered rozanolixizumab and FDA approval of nipocalimab for ages 12+, improving outpatient management of generalized MG.
WHO launches Coalition on Islamic Financing Towards Global Health to mobilize new resources
WHO and the Islamic Centre for Development of Trade announced a new coalition to leverage Islamic financing mechanisms to support global health priorities, aiming to expand sustainable funding for health programs in member states.